- Home
- ALTO vs SERA Comparison
ALTO vs SERA Comparison
Compare ALTO & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- SERA
- Stock Information
- Founded
- ALTO 2003
- SERA 2008
- Country
- ALTO United States
- SERA United States
- Employees
- ALTO N/A
- SERA N/A
- Industry
- ALTO Major Chemicals
- SERA Precision Instruments
- Sector
- ALTO Industrials
- SERA Health Care
- Exchange
- ALTO Nasdaq
- SERA Nasdaq
- Market Cap
- ALTO 90.6M
- SERA 90.6M
- IPO Year
- ALTO N/A
- SERA 2021
- Fundamental
- Price
- ALTO $1.05
- SERA $3.35
- Analyst Decision
- ALTO Strong Buy
- SERA
- Analyst Count
- ALTO 1
- SERA 0
- Target Price
- ALTO $5.50
- SERA N/A
- AVG Volume (30 Days)
- ALTO 242.5K
- SERA 44.6K
- Earning Date
- ALTO 11-05-2025
- SERA 11-05-2025
- Dividend Yield
- ALTO N/A
- SERA N/A
- EPS Growth
- ALTO N/A
- SERA N/A
- EPS
- ALTO N/A
- SERA N/A
- Revenue
- ALTO $933,137,000.00
- SERA $108,000.00
- Revenue This Year
- ALTO N/A
- SERA $217.92
- Revenue Next Year
- ALTO $7.53
- SERA $479.25
- P/E Ratio
- ALTO N/A
- SERA N/A
- Revenue Growth
- ALTO N/A
- SERA 0.94
- 52 Week Low
- ALTO $0.76
- SERA $1.37
- 52 Week High
- ALTO $2.05
- SERA $9.13
- Technical
- Relative Strength Index (RSI)
- ALTO 41.59
- SERA 56.36
- Support Level
- ALTO $1.01
- SERA $3.20
- Resistance Level
- ALTO $1.12
- SERA $3.95
- Average True Range (ATR)
- ALTO 0.05
- SERA 0.23
- MACD
- ALTO -0.01
- SERA 0.04
- Stochastic Oscillator
- ALTO 5.00
- SERA 56.19
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.